Doctor of Dentistry Program year 2023 Reported 2020–2023 Source: CMS Open Payments, 2026 publication

Robert Lazerson

Dentist, Oral and Maxillofacial Pathology Marietta, GA Doctor of Dentistry

NPI 1235248170 CMS profile 455535

3020 Roswell Rd, Suite 110, Marietta, GA 30062

Open in the dashboard

General payments

$5,014

72 records reported · program years 2020–2023

Research payments

$0

Paid to them · None reported · program years 2020–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Robert Lazerson of Marietta, GA is reported in the CMS Open Payments database as having received $5,014 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Dentist, Oral and Maxillofacial Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $468 10
2022 General $781 12
2021 General $2,639 35
2020 General $1,125 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Lazerson
  • Dentist, Oral and Maxillofacial Pathology median
  • Middle half of Dentist, Oral and Maxillofacial Pathology
  • National median

In program year 2025, general payments to Robert Lazerson were reported at $0. Among 128 Dentist, Oral and Maxillofacial Pathology profiles paid that year, the median was $91 and the middle half received between $35 and $330.

Show as a table
Year Robert Lazerson Dentist, Oral and Maxillofacial Pathology median Middle half National median
2019 $0 $106 $28–$326 $163
2020 $1,125 $109 $33–$500 $114
2021 $2,639 $104 $30–$557 $132
2022 $781 $104 $37–$432 $149
2023 $468 $152 $41–$372 $160
2024 $0 $100 $38–$354 $164
2025 $0 $91 $35–$330 $169

Breakdown

Who paid General payments · program years 2020–2023
  1. Zimmer Biomet Holdings, Inc. $3,900 52 payments
  2. Zimvie Inc. $1,025 19 payments
  3. Geistlich Pharma, North America, Inc. $89 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2023
  1. Education $4,650 62 payments
  2. Food and Beverage $364 10 payments
Products named General payments · program years 2020–2023
  1. Puros $750 10 payments
  2. Revitalize $675 9 payments
  3. Tapered Screw-Vent $550 12 payments
  4. Bellatek $525 7 payments
  5. Tapered Screw $375 5 payments
  6. T3 $225 3 payments
  7. TSV NG Surgical $225 3 payments
  8. Zimmer Abutments $225 3 payments
  9. 3i T3 $150 2 payments
  10. Diem2 $150 2 payments
  11. Other $1,014 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Pathology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record